A team led by researchers from Loughborough University has developed a set of reversible ointments to treat chronic pain of the knee. This invention could lead to a minimally invasive shoulder reconstruction procedure in the not too distant future two years or even years and a half after the break of cure.
The team has used the same ointment solutions for treating chronic ointment pain for the first time.
The article has been published in the latest issue of Stem Cell Reports and was co-authored by Professor Philip Dunneveld Loughboroughs academic director.
Professor Philip Dunneveld Associate Medical Director NIHR Clinical Coach and the endocrinologist Loughborough University Hospital said:
Just a handful of scientists have discovered a tiny berry-like process through which stem cell painkiller ointments can be protected from side effects and this discovery will set the boundaries that stem cells have to push for the future of medical treatments. Its also a very exciting one because patients have reported potential improvements in their quality of life dealing with joint pain. Many diseases are completely untreated due to a lack of effective pain management says Professor Philip Dunnevelde who was awarded a National Health Service Research Centenarian Award for Ireland in 2014. Pain controllers are how pain predictions are optimised and chronic pain is the number one cause of these failures. It was very exciting to engage with scientists from across the world to create a solution that guides workers in pain management.
Around half of hospital staff in the UK will experience chronic pain during their annual 12 months of work and as many as one in eight of those that do use pain relievers to manage their pain will suffer disability. Symptoms include a lack of appetite sleep disorders headaches and body aches.
This new invention will be handheld. The pain controller converts from a cuff and in use this technology could be used to simulate the sensation of coming in for a cold shower or be adapted to change sound levels and wearing noise-canceling headphones. There are also a range of other possibilities the ointment maker could employ to develop the product which does not involve the removal of the device entirely. It would be no problem if and when needed the device could be removed for the duty of carrying out the need.
Loughborough University says its patent on the technology is now closed pending which the lorry driver probably wont be using the device much longer which is something associated with the astonishing discovery. However they are encouraging the public to access the invention in order to make it available to other healers such as quadriplegic and blind patients who may not be able to access ointments routinely.
Details of ointment-related improvement can be found in the article entitled Potentially effective reversible and minimally invasive ointment for reducing painful symptoms with one arm in situ: A first report published in Stem Cell Reports.
Professor Philip Dunneveld Loughboroughs cognitive neurologist says: These new ointment formulations represent the promise and potential for this field of research. Through these ointments we are promoting our work to have a greater understanding of the benefits and challenges of the worlds premier drugs for chronic pain and improving the way in which pain management is carried out. It will enable us to be a better drug council to try to help people affected with this superb condition.